Favorable outcome of amphotericin B treatment of zygomycotic necrotizing fascitis caused by Apophysomyces elegans

International Journal of Dermatology

Volumn 47, Issue 4, 2008, Pages 407-409

  Devi, Sheela C ^a   Kanungo, Reba ^a   Barreto, Elvino ^a   Thomas, Abraham G ^a   Shashikala, Nair ^a   Srinivasan, S ^a   Anitha, Patricia K ^a  

^a PONDICHERRY INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; AMPICILLIN; CEFAZOLIN; CEFOTAXIME; CIPROFLOXACIN; CREATININE; CRYSTAL VIOLET; GENTAMICIN; GLUCOSE; IMIPENEM; OFLOXACIN; SULPERAZON; TICARCILLIN; UREA;

ACCIDENTAL INJURY; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; APOPHYSOMYCES ELEGANS; ARTICLE; CASE REPORT; CLAVICLE FRACTURE; CREATININE BLOOD LEVEL; DEBRIDEMENT; EOSINOPHIL COUNT; ESCHERICHIA COLI; FUNGUS HYPHAE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HOSPITAL ADMISSION; HUMAN; INCUBATION TIME; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE COUNT; MALE; MUCORMYCOSIS; MULTIDRUG RESISTANCE; NECROTIZING FASCIITIS; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PSEUDOMONAS AERUGINOSA; SEPTICEMIA; SHOULDER; SKIN TRANSPLANTATION; SPLIT THICKNESS SKIN GRAFT; SPOROGENESIS; TREATMENT OUTCOME; UREA BLOOD LEVEL; WOUND INFECTION; ZYGOMYCETES;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DEBRIDEMENT; FASCIITIS, NECROTIZING; HUMANS; MALE; MIDDLE AGED; MUCORALES; MUCORMYCOSIS; SKIN TRANSPLANTATION; WOUND INFECTION;

EID: 41749096590     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03622.x     Document Type: Article

References (14)

1. Ellis JJ, Ajello L. An unusual source of Apophysomyces elegans and a method of stimulating sporulation of Saksenaea vasiformis. Mycologia 1982; 74: 144-145.
2. Misra PC, Srivastava KJ, Lata K. Apophysomyces, a new genus of the Mucorales. Mycotaxon 1979; 8: 377-382.
3. Rippon JW. Zygomycosis. In: Medical Microbiology, 3rd edn. Philadelphia, PA: W.B. Saunders, 1988: 685.
4. Chakrabarti A, Ghosh A, Prasad GS, et al. Apophysomyces elegans: An emerging zygomycete in India. J Clin Microbiol 2003; 41: 783-788.
5. Winn RE, Ramsey PD, Adams ED. Traumatic mucormycosis secondary to Apophysomyces elegans, a new genus of the Mucorales. Clin Res 1985; 30: 382A.
6. Cooter RD, Lim IS, Ellis DH, Leitch IO. Burn wound zygomycosis caused by Apophysomyces elegans. J Clin Microbiol 1990; 28: 2151-2153.
7. Chakrabarti A, Kumar P, Padhye AA, et al. Primary cutaneous zygomycosis due to Saksenaea vasiformis and Apophysomyces elegans. Clin Infect Dis 1997; 24: 580-583.
8. Lakshmi V, Sudha Rani T, Savitri S, et al. Zygomycotic necrotizing fascitis caused by Apophysomyces elegans. J Clin Microbiol 1993; 31: 1368-1369.
9. Liang KP, Tleyjeh IM, Wilson WR, et al. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans. J Clin Microbiol 2006; 44: 892-898.
10. Meis JFGM, Kullberg BJ, Pruszczynski M, Veth PH. Severe osteomyelitis due to zygomycete Apophysomyces elegans. J Clin Microbiol 1994; 32: 3078-3081.
11. Kimura M, Smith MB, McGinnis MR. Zygomycosis due to Apophysomyces elegans. Arch Pathol Lab Med 1999; 123: 386-390.
12. Arvind A, Padhye AA, Ajello L. Simple method of inducing sporulation by Apophysomyces elegans and Saksenaea vasiformis. J Clin Microbiol 1988; 26: 1861-1863.
13. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13: 236-301.
14. Sugar AM, Liu XP. Combination of antifungal therapy in treatment of murine pulmonary mucormycosis: Roles of quinolones and azoles. Antimicrob Agents Chemother 2000; 44: 2004-2006.